Novartis and the Broad Institute develop a new "cancer encyclopaedia"

Paving the way for a more targeted treatment of cancer patients.

By New Statesman Published 29 March 2012
Novartis's headquarters in Basel, Switzerland. Credit: Getty Images
Novartis's headquarters in Basel, Switzerland. Credit: Getty Images

The Swiss pharmaceutical company Novartis and the research firm the Broad Institute have developed a new encyclopaedia cataloguing the genetic and molecular profiles of almost 1,000 human cancer cell lines.

 
 

Latest tweets